Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.

J Hematol Oncol · 2017 · PMC5259921 · PMID 28118857

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

showed a trendp = 0.083so close (0.05 < p ≤ 0.1)

No significant factor was associated with the risk of relapse in this study, although older age (>50 years) showed a trend to an increased risk (HR = 1.39, 95% CI, 0.96–2.00; p = 0.083).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.